Bio-Techne Corp(TECH-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low70.84
Day High70.98
Open:70.92
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Concentra Group Holdings Parent, Inc. (CON) and Palvella Therapeutics (PVLA)
Tipranks
Bio-Techne (TECH) was downgraded to a Hold Rating at TD Cowen
Tipranks
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)
StockStory
1 Momentum Stock with Impressive Fundamentals and 2 We Find Risky
WWD
Tipranks
Bio-Techne to Be Acquired by Merck KGaA
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Bio-Techne (TECH)
Tipranks
Merck to Acquire Bio-Techne in Cash Deal
Motley Fool
Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer
StockStory
Why Bio-Techne (TECH) Stock Is Trading Up Today
TECH
Tipranks
TD Cowen Sticks to Their Buy Rating for Bio-Techne (TECH)
StockStory
1 S&P 500 Stock with Impressive Fundamentals and 2 We Brush Off
GM
StockStory
3 Reasons TECH is Risky and 1 Stock to Buy Instead
TECH
StockStory
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
ACVA
Tipranks
Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Bio-Techne (TECH) and Agilent (A)
StockStory
2 Healthcare Stocks to Research Further and 1 We Find Risky
RMD
StockStory
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call
TECH
Motley Fool
Investment Firm Sells $12.2 Million Worth of Materials Stock, According to Latest SEC Filing
StockStory
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down
GLW
Tipranks
Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Mineralys Therapeutics, Inc. (MLYS)

Profile

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.